GTC
DTIL icon

Ghost Tree Capital’s Precision BioSciences DTIL Stock Holding History

Ghost Tree Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,667
Closed -$2.07M – 58
2021
Q1 		$2.07M Buy
+6,667
New +$2.33M 0.49% 44

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ghost Tree Capital's DTIL Position: Q2 2021 in Review

Ghost Tree Capital sold out of Precision BioSciences (DTIL) in Q2 2021, closing a stake of 6,667 shares — an estimated $2.07M sold.

Ghost Tree Capital first reported a position in DTIL in Q1 2021 and held it in 1 quarter. The position peaked at $2.07M in Q1 2021. 130 funds tracked by Wall St. Rank hold DTIL as of Q2 2021.

  • Ghost Tree Capital reported no remaining Precision BioSciences position as of Q2 2021 after selling out during the quarter.
  • Ghost Tree Capital sold 6,667 Precision BioSciences shares in Q2 2021, an estimated $2.07M.
  • Ghost Tree Capital first reported a position in Precision BioSciences in Q1 2021 and held it in 1 quarter.
  • Ghost Tree Capital's Precision BioSciences position peaked at $2.07M in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2021.

Based on Ghost Tree Capital's 13F filing for Q2 2021, filed 11 Aug 2021.